Embassy Developments’ promoters have successfully converted the final tranche of warrants, bringing the total promoter infusion to ₹1,160 crore. Recently, ₹67.7 crore was converted into equity at ₹111.51 per share, marking full subscription of all outstanding warrants.
With this infusion, the promoter and promoter group’s shareholding in Embassy Developments Ltd (EDL) now stands at 41.4%, reinforcing promoter confidence in the company’s growth trajectory.
The capital infusion is intended to strengthen the company’s balance sheet, accelerate completion of ongoing projects, and support expansion plans across key markets such as Bengaluru, Delhi NCR, and Mumbai Metropolitan Region.
Embassy’s CFO, Rajesh Kaimal, cited the infusion as a clear indicator of the promoters’ long-term commitment, noting that the enhanced equity base puts the company in a stronger position to execute new projects and pursue strategic opportunities.
The warrant conversion process has resulted in the allotment of approximately 10.4 crore fully paid-up equity shares (face value ₹2 each). These shares were issued to promoters and associated entities under the conversion scheme.
This completes a multi-tranche fundraising effort by the promoters, who had earlier infused capital through warrant issuances. With the equity base now fortified, Embassy is better placed to manage project funding, reduce leverage risks, and maintain financial flexibility in the near term.
As Embassy moves forward with its ambitious development pipeline, this infusion is likely to be a key pillar in its ability to meet delivery timelines, raise fresh capital, and strengthen its position across India’s competitive real estate markets.
Also Read: Arnya Real estates Commits Rs 415 Crore to Residential Projects in Bengaluru & Navi Mumbai
